Logo image of ESIGM.MI

ESI SPA (ESIGM.MI) Stock Fundamental Analysis

Europe - BIT:ESIGM - IT0005421885 - Common Stock

1.74 EUR
-0.01 (-0.57%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ESIGM scores 4 out of 10 in our fundamental rating. ESIGM was compared to 42 industry peers in the Construction & Engineering industry. While ESIGM seems to be doing ok healthwise, there are quite some concerns on its profitability. ESIGM is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ESIGM had positive earnings in the past year.
ESIGM had a positive operating cash flow in the past year.
In multiple years ESIGM reported negative net income over the last 5 years.
In multiple years ESIGM reported negative operating cash flow during the last 5 years.
ESIGM.MI Yearly Net Income VS EBIT VS OCF VS FCFESIGM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

ESIGM has a worse Return On Assets (0.56%) than 78.57% of its industry peers.
Looking at the Return On Equity, with a value of 3.90%, ESIGM is doing worse than 71.43% of the companies in the same industry.
ESIGM has a Return On Invested Capital of 5.74%. This is comparable to the rest of the industry: ESIGM outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA 0.56%
ROE 3.9%
ROIC 5.74%
ROA(3y)-1.53%
ROA(5y)2.18%
ROE(3y)-12.46%
ROE(5y)-1.13%
ROIC(3y)N/A
ROIC(5y)N/A
ESIGM.MI Yearly ROA, ROE, ROICESIGM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Profit Margin, with a value of 0.48%, ESIGM is doing worse than 78.57% of the companies in the same industry.
ESIGM's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.60%, ESIGM is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
ESIGM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 12.68%, ESIGM is doing worse than 83.33% of the companies in the same industry.
In the last couple of years the Gross Margin of ESIGM has declined.
Industry RankSector Rank
OM 1.6%
PM (TTM) 0.48%
GM 12.68%
OM growth 3Y21.12%
OM growth 5YN/A
PM growth 3Y-11.84%
PM growth 5YN/A
GM growth 3Y-3.75%
GM growth 5YN/A
ESIGM.MI Yearly Profit, Operating, Gross MarginsESIGM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 100 150

4

2. Health

2.1 Basic Checks

ESIGM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ESIGM has been increased compared to 1 year ago.
Compared to 1 year ago, ESIGM has an improved debt to assets ratio.
ESIGM.MI Yearly Shares OutstandingESIGM.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ESIGM.MI Yearly Total Debt VS Total AssetsESIGM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that ESIGM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.78, ESIGM is in line with its industry, outperforming 47.62% of the companies in the same industry.
The Debt to FCF ratio of ESIGM is 2.43, which is a good value as it means it would take ESIGM, 2.43 years of fcf income to pay off all of its debts.
ESIGM's Debt to FCF ratio of 2.43 is fine compared to the rest of the industry. ESIGM outperforms 71.43% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that ESIGM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.28, ESIGM is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.43
Altman-Z 1.78
ROIC/WACC0.76
WACC7.54%
ESIGM.MI Yearly LT Debt VS Equity VS FCFESIGM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 1.13 indicates that ESIGM should not have too much problems paying its short term obligations.
The Current ratio of ESIGM (1.13) is comparable to the rest of the industry.
ESIGM has a Quick Ratio of 1.13. This is a bad value and indicates that ESIGM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.26, ESIGM is doing worse than 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.26
ESIGM.MI Yearly Current Assets VS Current LiabilitesESIGM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 213.12% over the past year.
Measured over the past years, ESIGM shows a very strong growth in Earnings Per Share. The EPS has been growing by 115.72% on average per year.
ESIGM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.49%.
ESIGM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 146.66% yearly.
EPS 1Y (TTM)213.12%
EPS 3Y115.72%
EPS 5YN/A
EPS Q2Q%281.46%
Revenue 1Y (TTM)-14.49%
Revenue growth 3Y146.66%
Revenue growth 5YN/A
Sales Q2Q%-11.31%

3.2 Future

ESIGM is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.61% yearly.
Based on estimates for the next years, ESIGM will show a very strong growth in Revenue. The Revenue will grow by 22.71% on average per year.
EPS Next Y-17.5%
EPS Next 2Y-2.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.2%
Revenue Next 2Y25.09%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ESIGM.MI Yearly Revenue VS EstimatesESIGM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ESIGM.MI Yearly EPS VS EstimatesESIGM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

ESIGM is valuated cheaply with a Price/Earnings ratio of 6.69.
97.62% of the companies in the same industry are more expensive than ESIGM, based on the Price/Earnings ratio.
ESIGM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
With a Price/Forward Earnings ratio of 4.80, the valuation of ESIGM can be described as very cheap.
ESIGM's Price/Forward Earnings ratio is rather cheap when compared to the industry. ESIGM is cheaper than 97.62% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. ESIGM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.69
Fwd PE 4.8
ESIGM.MI Price Earnings VS Forward Price EarningsESIGM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ESIGM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ESIGM is more expensive than 69.05% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ESIGM is valued a bit more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.38
EV/EBITDA 17.16
ESIGM.MI Per share dataESIGM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as ESIGM's earnings are expected to decrease with -2.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ESIGM!.
Industry RankSector Rank
Dividend Yield N/A

ESI SPA

BIT:ESIGM (9/5/2025, 7:00:00 PM)

1.74

-0.01 (-0.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.10M
Analysts84.44
Price Target2.55 (46.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.69
Fwd PE 4.8
P/S 0.44
P/FCF 22.38
P/OCF 18.13
P/B 3.56
P/tB 4.35
EV/EBITDA 17.16
EPS(TTM)0.26
EY14.94%
EPS(NY)0.36
Fwd EY20.84%
FCF(TTM)0.08
FCFY4.47%
OCF(TTM)0.1
OCFY5.52%
SpS3.98
BVpS0.49
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 3.9%
ROCE 9.47%
ROIC 5.74%
ROICexc 9.37%
ROICexgc 11.87%
OM 1.6%
PM (TTM) 0.48%
GM 12.68%
FCFM 1.95%
ROA(3y)-1.53%
ROA(5y)2.18%
ROE(3y)-12.46%
ROE(5y)-1.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y168.74%
ROICexcg growth 5YN/A
ROICexc growth 3Y186.11%
ROICexc growth 5YN/A
OM growth 3Y21.12%
OM growth 5YN/A
PM growth 3Y-11.84%
PM growth 5YN/A
GM growth 3Y-3.75%
GM growth 5YN/A
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.43
Debt/EBITDA 1.42
Cap/Depr 55.73%
Cap/Sales 0.46%
Interest Coverage 250
Cash Conversion 99.74%
Profit Quality 408.23%
Current Ratio 1.13
Quick Ratio 0.26
Altman-Z 1.78
F-Score6
WACC7.54%
ROIC/WACC0.76
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)213.12%
EPS 3Y115.72%
EPS 5YN/A
EPS Q2Q%281.46%
EPS Next Y-17.5%
EPS Next 2Y-2.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.49%
Revenue growth 3Y146.66%
Revenue growth 5YN/A
Sales Q2Q%-11.31%
Revenue Next Year8.2%
Revenue Next 2Y25.09%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y140.4%
EBIT growth 3Y198.75%
EBIT growth 5YN/A
EBIT Next Year13.94%
EBIT Next 3Y15.12%
EBIT Next 5YN/A
FCF growth 1Y91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.91%
OCF growth 3YN/A
OCF growth 5YN/A